Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay-Renke Schmidt

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
American Journal of Nephrology|January 11, 2018
Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 DiabetesSusanne Triebswetter, Lena J Gutjahr-Lengsfeld, Kay-Renke Schmidt, et al.
Kidney International|March 1, 2016
Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysisVera Krane, Kay-Renke Schmidt, Lena J Gutjahr-Lengsfeld, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
American Journal of Nephrology|January 11, 2018
Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 DiabetesSusanne Triebswetter, Lena J Gutjahr-Lengsfeld, Kay-Renke Schmidt, et al.
Kidney International|March 1, 2016
Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysisVera Krane, Kay-Renke Schmidt, Lena J Gutjahr-Lengsfeld, et al.
Pageof 1